Use of Preclinical Dog Studies and Absorption Modeling to Facilitate Late Stage Formulation Bridging for a BCS II Drug Candidate
Year: 2013
Type: article
Source: AAPS PharmSciTech
Author: Filippos Kesisoglou
Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)
Language: English
Subfield: Pharmaceutical Science
Domain: Life Sciences
Open Access status: bronze
OpenAlex ID: W1988561985